DuPont’s Nutrition & Health segment in 1Q17

DuPont’s (DD) Nutrition & Health Segment, its third-largest revenue contributor, accounted for 10.2% of its revenue in 1Q17. The segment reported revenue of $789 million in 1Q17, a decline of 1.5% from the 1Q16 revenue of $802 million.

Why DuPont’s Nutrition & Health Revenue Fell

The sales volume decline in protein solutions and systems and texturants impacted the segment’s revenue in 1Q17. This effect was extended by foreign exchange hedging. However, on the positive side, probiotics and emulsifiers saw volume growth.

Operating earnings and margin

The Nutrition & Health segment reported a net income of $121 million in 1Q17, compared with $104 million in 1Q16, an increase of 16.3% YoY (year-over-year). The segment’s margin improved from 13% in 1Q16 to 15.3% in 1Q17, an increase of 230 basis points YoY. The segments income and margin improvements were primarily due to improved productivity and cost savings.

Segment’s outlook

Although volume growth in probiotics and emulsifiers is expected to continue, growth in protein solutions and systems and texturants may pose a problem. Also, foreign currency translation challenges remain and could impact the segment’s revenue.

Investors can indirectly hold DuPont by investing in the ProShares Ultra Basic Materials ETF (UYM), which has invested 8.3% of its portfolio in DuPont. Other top holdings of the fund include The Dow Chemical Company (DOW), Monsanto (MON), and Praxair (PX), which had weights of 8.4%, 6.0%, and 4.1%, respectively, as of April 25, 2017. In the next part, we will analyze the Performance Materials segment’s performance in 1Q17.

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.